
DD Adds FilmTec MXP RO-8038-FF Element to its Dairy Portfolio
DuPont launches FilmTec MXP RO-8038-FF for dairy processors, delivering up to 50% higher productivity and seamless changeover in mesh-wrapped systems.
Loading news...

DuPont launches FilmTec MXP RO-8038-FF for dairy processors, delivering up to 50% higher productivity and seamless changeover in mesh-wrapped systems.

Compass Minerals International (NYSE: CMP - Get Free Report) and DuPont de Nemours (NYSE: DD - Get Free Report) are both basic materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, risk, dividends and earnings. Insider and Institutional Ownership 99.8%

Bessemer Group Inc. increased its holdings in DuPont de Nemours, Inc. (NYSE: DD) by 51.4% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 112,255 shares of the basic materials company's stock after buying an additional 38,122 shares during the
DD launches Liveo C6-8XX medical-grade liquid silicone rubber, offering lower viscosity, faster molding and USP Class VI compliance for advanced devices.

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for DuPont de Nemours (DD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.

New FilmTec™ MXP RO-8038-FF reverse osmosis element provides enhanced productivity and operational performance in a mesh wrapped configuration, enabling high-quality dairy products WILMINGTON, Del., Feb. 4, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced the launch of the FilmTec™ MXP RO-8038-FF element—an advanced mesh wrapped reverse osmosis solution engineered for dairy processors who rely on mesh wrapped systems and now seek greater active area and higher productivity.
Improved-rheology medical-grade LSR offers process flexibility for fabricating medical devices, including devices intended for implantation in humans for less than 30 days, as well as for non-implant applications WILMINGTON, Del., Feb. 3, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced the launch of Liveo™ C6-8XX Liquid Silicone Rubber (LSR), a new USP Class VI (C6) series of medical-grade, two-part silicone elastomers engineered to meet the stringent requirements of medical device applications.

Bank of New York Mellon Corp raised its position in shares of DuPont de Nemours, Inc. (NYSE: DD) by 0.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,169,908 shares of the basic materials company's stock after

DD unveils AmberLite FPA57 resin, boosting organic acid purification with longer cycles, higher capacity and less waste.

Microsoft stock crashed 12% - but MSFT's $150B capex surge isn't a warning sign. It's a buy signal for AI infrastructure investors.

Upgraded weak base anion resin delivers enhanced operating capacity, longer run lengths, and greater fouling resistance to support cost-efficient production of lactic and citric acids WILMINGTON, Del., Jan. 28, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced the launch of DuPont™ AmberLite™ FPA57 resin, an innovative weak base anion resin designed to support the growing needs of organic acid manufacturers.

Applications now being accepted for this awards program recognizing excellence in healthcare packaging initiatives that utilize Tyvek® to help drive and promote continued innovation in sustainability WILMINGTON, Del., Jan. 26, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that it is accepting applications for the 3rd annual global Tyvek® Sustainable Healthcare Packaging Awards program.

Cullen Frost Bankers Inc. lowered its position in shares of DuPont de Nemours, Inc. (NYSE: DD) by 6.4% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 223,717 shares of the basic materials company's stock after selling

Wealth Enhancement Advisory Services LLC increased its stake in shares of DuPont de Nemours, Inc. (NYSE: DD) by 14.4% during the undefined quarter, according to its most recent filing with the SEC. The institutional investor owned 150,841 shares of the basic materials company's stock after acquiring an additional 18,950 shares during the period.

WILMINGTON, Del., Jan. 21, 2026 /PRNewswire/ -- DuPont (NYSE: DD) will release its fourth quarter and full year 2025 financial results at 6:00 a.m.

Anchor Capital Advisors LLC lifted its holdings in shares of DuPont de Nemours, Inc. (NYSE: DD) by 13.6% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 749,998 shares of the basic materials company's stock after acquiring an additional 89,745 shares during the

WILMINGTON, Del., Jan. 20, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced the appointment of D.G.

Massachusetts Financial Services Co. MA cut its stake in shares of DuPont de Nemours, Inc. (NYSE: DD) by 60.1% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,206,515 shares of the basic materials company's stock after selling 4,832,984 shares during the period.

Ashtead has also been moving its primary listing to the New York Stock Exchange, which we believe will lift its valuation. Wells Fargo delivered strong earnings results driven by higher revenue, improved credit quality and higher investment banking fees. Merck reported earnings and revenues that beat expectations, driven by strong sales of its cancer treatment Keytruda and its pulmonary arterial hypertension therapy WinReva.

DuPont de Nemours, Inc. (NYSE: DD - Get Free Report) has earned a consensus rating of "Moderate Buy" from the fifteen ratings firms that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, four have given a hold rating and ten have issued a buy rating on